Maze Therapeutics, Inc. Common Stock (MAZE) earnings · $525.3M cap
These earnings events as JSON? API free 100/dayMaze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
This MAZE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MAZE revenue for 2026-03-31 was $20.0M. Net income was -$24.2M. MAZE currently screens at market cap $525.3M.
When the next MAZE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for MAZE. We will not invent a beat or miss.
Not investment advice. Full MAZE research stays on the stock page; the tape stays on the quote page.
MAZE earnings FAQ
What are MAZE's latest revenue and net income?
Latest cached Maze Therapeutics, Inc. Common Stock (MAZE) revenue for Mar 31, 2026 was $20.0M. Net income was -$24.2M. Statements: https://lician.com/financials/maze
What period does the latest MAZE earnings print cover?
The latest cached Maze Therapeutics, Inc. Common Stock (MAZE) earnings print covers Mar 31, 2026. The prior cached period on this page is Jun 30, 2025.
Where are MAZE earnings listed?
Cached earnings facts for Maze Therapeutics, Inc. Common Stock (MAZE) are listed at https://lician.com/earnings/maze. Statements: https://lician.com/financials/maze
Not investment advice.